Veracyte reported $971.18M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 763.03M 47.8M
Agenus AGEN:US $ -228.84M 61.78M
Agilent A:US $ 4946M 136M
Anika Therapeutics ANIK:US $ 286.8M 10.15M
Arrowhead Research ARWR:US $ 436.89M 8.66M
Biocept BIOC:US $ 29.35M 2.58M
Bruker BRKR:US $ 1015.4M 47.7M
Dicerna Pharmaceuticals DRNA:US $ 111.07M 15.33M
Exact Sciences EXAS:US $ 3559.1M 89.89M
Genmark Diagnostics GNMK:US $ 94.2M 0.24M
Heron Therapeutics HRTX:US $ 160.11M 36.11M
Illumina ILMN:US $ 5180M 258M
Immunogen IMGN:US $ 68.46M 25.66M
Intrexon XON:US $ 159.2M 15.6M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Laboratory Of America LH:US $ 10245.1M 223.6M
Ligand Pharmaceuticals LGND:US $ 786.52M 40.68M
Luminex LMNX:US $ 488.05M 29.66M
Myriad Genetics MYGN:US $ 902.5M 27.3M
Rigel Pharmaceuticals RIGL:US $ 68.11M 10.19M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Siemens SIE:GR € 42075M 1949M
Sonic Healthcare SHL:AU $ 6.38B 555.65M
Thermo Fisher Scientific TMO:US $ 36854M 1796M
Veracyte VCYT:US $ 971.18M 3.05M
Waters WAT:US $ 268.27M 37.31M